New toolkit aims to boost HIV prevention in african american women
NCT ID NCT05139069
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a special toolkit designed to help African American women at risk for HIV get access to PrEP (a daily pill that prevents HIV). The toolkit also addresses intimate partner violence, which can make it harder for women to seek prevention. Researchers worked with two clinics in Mississippi and enrolled 27 healthcare providers to see if the toolkit increased PrEP prescriptions and follow-up visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Trauma-Informed Toolkit (behavioral intervention)
What this could lead to
If successful, this toolkit could help more African American women access HIV prevention medication, especially those facing intimate partner violence.
What could go wrong
This was a small pilot study with only 27 participants, so results may not apply broadly. The toolkit is behavioral, not a drug, so its impact on HIV rates is indirect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, 21220, United States